Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study

The overall 60-month drug survival for treatments prescribed in IBS is relatively low, suggesting that the effectiveness of current therapies remains limited. Among the medications studied, simethicone and TCAs demonstrated the best drug survival rates.

Authors

Institutions

Publication Details

Journal
Neurogastroenterology & Motility
Published
2025-04-24
DOI
https://doi.org/10.1111/nmo.70063
Citations
1
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
1.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study

Pontus Karling, Alice Sandberg‐Janzon
1 citations
Neurogastroenterology & Motility
Gastrointestinal motility and disorders
1.81
article

Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study

Pontus Karling, Alice Sandberg‐Janzon
article en
1 citations

Abstract

The overall 60-month drug survival for treatments prescribed in IBS is relatively low, suggesting that the effectiveness of current therapies remains limited. Among the medications studied, simethicone and TCAs demonstrated the best drug survival rates.

Neurogastroenterology & MotilityVol. 37(10)
Umeå University (SE)
Good health and well-being
Openalex Percentile: Top 18%
Gastrointestinal motility and disorders
1.81
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study — Pontus Karling, Alice Sandberg‐Janzon · Neurogastroenterology & Motility (2025) | TGRS Research Map | TGRS